
Congratulations to Michelle Doyle!
Michelle is a graduate student here at UT Health, and her R36 grant application "Role of Dopamine D3 and Serotonin 2C Receptors in the Development of an Addiction-like Phenotype in Rats" was funded!
The mission of the ARTT Center of Excellence is to promote addiction research, treatment, and training at UT Health San Antonio and facilitate the translation of discoveries in basic science to clinical care. ARTT provides a formal mechanism for bringing together a diverse group of scientists, clinicians, and educators in order to identify and develop novel behavioral and pharmacological approaches to treating addiction.
The vision of the ARTT Center of Excellence is to stimulate innovative research leading to breakthroughs in the treatment of substance use disorders and to train the next generation of addiction scientists and clinicians.
Members in the ARTT Center of Excellence represent a wide range of scientific and clinical perspectives, from chemistry to biology and behavior. Researchers, educators, and clinicians at UT Health San Antonio are on the cutting edge of addiction science and are making significance advances in the understanding and treatment of substance use disorders.
This three-day conference focuses on translational aspects of addiction research among chemists, biologists, and behavioral scientists.
Learn More!Postdoctoral fellows receive SUD interdisciplinary training across various laboratories and areas of expertise.
Learn More!The UT Health Behavioral Wellness Clinic (Be Well) is a comprehensive substance use treatment program treating a wide variety of substance dependence problems.
Learn More!TxSUS represents a unique opportunity to bring together health care providers and community members to collaboratively identify substance use challenges and solutions.
Learn More!Virtual Event
Virtual Event
Michelle is a graduate student here at UT Health, and her R36 grant application "Role of Dopamine D3 and Serotonin 2C Receptors in the Development of an Addiction-like Phenotype in Rats" was funded!
UT Health San Antonio professor Charles France, PhD, said the drug is a form on morphine but it is 10 times more potent than morphine.
Kelly McGlothen-Bell, PhD, RN, a posdoctoral fellow in Dr. Lisa Cleveland's lab, was accepted to the Summer Genetics Institute (SGI), an intensive research training program at the National Institutes of Health (NIH) in Bethesda, Maryland.